Skip to main content
Download PDF

Correction to: Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease

BMC Neurology volume 20, Article number: 80 (2020) Cite this article

The Original Article was published on 31 October 2019

Correction to: BMC Neurol

https://doi.org/10.1186/s12883-019-1498-9

Following publication of the original article [1], the authors ask to correct the surname of co-author Dennis Hedderich from from Heddderich to Hedderich.

Reference

  1. Ortner M, Drost R, Heddderich D, Goldhardt O, Muller-Sarnowski F, Diehl-Schmid J, Forstl H, Yakushev I, Grimmer T. Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer's disease. BMC Neurol. 2019;19:264. https://doi.org/10.1186/s12883-019-1498-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry and Psychotherapy, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany

    Marion Ortner, René Drost, Oliver Goldhardt, Felix Müller-Sarnowski, Janine Diehl-Schmid, Hans Förstl & Timo Grimmer

  2. Department of Diagnostic and Interventional Neuroradiology, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany

    Dennis Hedderich

  3. Department of Nuclear Medicine, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany

    Igor Yakushev

Authors
  1. Marion Ortner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. René Drost
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dennis Hedderich
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Oliver Goldhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Felix Müller-Sarnowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Janine Diehl-Schmid
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hans Förstl
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Igor Yakushev
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Timo Grimmer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marion Ortner.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ortner, M., Drost, R., Hedderich, D. et al. Correction to: Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease. BMC Neurol 20, 80 (2020). https://doi.org/10.1186/s12883-020-01649-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12883-020-01649-9

BMC Neurology

ISSN: 1471-2377

Contact us